Biocon Limited (BOM: 532523)
India
· Delayed Price · Currency is INR
401.05
+8.35 (2.13%)
At close: Jan 20, 2025
Biocon Employees
Biocon had 16,315 employees as of March 31, 2024. The number of employees decreased by 230 or -1.39% compared to the previous year.
Employees
16,315
Change (1Y)
-230
Growth (1Y)
-1.39%
Revenue / Employee
9.13M INR
Profits / Employee
882.13K INR
Market Cap
467.41B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
Reliance Industries | 347,362 |
Tata Consultancy Services | 601,546 |
HDFC Bank | 213,527 |
Bharti Airtel | 23,628 |
ICICI Bank | 187,765 |
Infosys | 317,240 |
State Bank of India | 232,296 |
ITC Limited | 37,312 |
Biocon News
- 5 days ago - CCI penalises investment manager of Goldman Sachs AIF for failing to notify Biocon deal - The Times of India
- 5 days ago - Stock Market Update, January 16: BSE and Biocon hit new 52-week highs today - Business Upturn
- 5 days ago - Pharma sector stocks: Biocon (+3.10%), Aurobindo Pharma (+0.48%), Divis Labs (+0.39%) rise; Mankind Pharma (-1.43%) leads losers - Business Upturn
- 7 days ago - Pharma Stocks Today: Biocon surges 4.41%, Mankind Pharma up 1.85%; Glaxo and Abbott India decline - Business Upturn
- 7 days ago - Biocon shares surge nearly 4% as HSBC upgrades to ‘Buy’ - Business Upturn
- 7 days ago - HSBC upgrades Biocon to ‘Buy’, raises target price to ₹430 - Business Upturn
- 8 days ago - Biocon shares surge 4% today; Motilal Oswal upgrades stock to Buy - Business Upturn
- 8 days ago - Pharma stocks: Biocon up 3.84% on US FDA nod for Malaysia unit; Divi’s Lab gains 0.61%, Mankind Pharma slips 3.75%, GlaxoSmithKline drops 2.42% - Business Upturn